45 deaths in CD12 (bad for patients, great for tri
Post# of 148169
(Total Views: 832)
Posted On: 09/30/2020 1:04:38 PM
45 deaths in CD12 (bad for patients, great for trial)
I believe (Techguru, Borel or others can say with better certainty than I) that 23 deaths in Leronlimab and 22 in placebo, yields p=0.012.
I was most afraid that there would be an insufficient number of deaths.
If leronlimab works as we believe, this seems to be as good an opportunity for which one could ask.
I believe (Techguru, Borel or others can say with better certainty than I) that 23 deaths in Leronlimab and 22 in placebo, yields p=0.012.
I was most afraid that there would be an insufficient number of deaths.
If leronlimab works as we believe, this seems to be as good an opportunity for which one could ask.
(6)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼